
| 2012 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | 900-1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | 70 |
| Total Project Funding: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Partner Constancy: | 46 |
| Project Leadership Index: | 75 |
| Diversity Index: | 60 |
| 2011 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2009 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2008 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2020 | 0 | 6.000.000 | 357.896 | 1 | ||
| 2017 | 0 | 3.991.096 | 452.375 | 1 | ||
| 2012 | 0 | 5.870.815 | 587.082 | 1 | ||
| 2011 | 0 | 5.953.832 | 196.350 | 1 | ||
Total number of partners: 49
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 49
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2020-01-01 | RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. | RESCUER | participant | 6.000.000 | 17 |
| 2017-01-01 | 3-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration | ArrestAD | participant | 3.991.096 | 8 |
| 2012-11-01 | Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia | NGS-PTL | participant | 5.870.815 | 10 |
| 2011-12-01 | European Clinical trials in Rare Sarcomas within an integrated translational trial network | EUROSARC | participant | 5.953.832 | 18 |